Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Diet and fasting combo shows promise for Alzheimer's patients

NCT ID NCT06898424

First seen Apr 02, 2026 · Last updated May 19, 2026 · Updated 10 times

Summary

This study looked at whether a plant-based ketogenic diet combined with intermittent fasting (called Ketoflex 12/3) could slow the progression of early-to-mid stage Alzheimer's disease. 60 adults aged 50-85 with mild to moderate Alzheimer's followed the diet, and researchers measured changes in their memory and thinking skills. The goal was to see if this dietary approach could help manage the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE (AD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Istanbul Medipol Universitesi

    Istanbul, 34214, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.